-
[Cell Biomaterials] Fully active zinc nitroprusside nanomedicine transforms cisplatin into chemoimmunotherapeutic agent for robust hepatocellular carcinoma therapy
2026-01-22
-
[Nature Communications] Variations in the Natural History of High-Risk HPV Types Following HPV-16/18 Bivalent Vaccination in Females Aged 18-45 Years
2026-01-16
-
[Science Translational Medicine] An antibody cocktail targeting conserved, nonoverlapping epitopes prevents viral escape and confers protection against RSV in vivo
2026-01-15
-
[Nature Communications] A broadly neutralizing antibody confers cross-genus protection against alphaherpesviruses by inhibiting gB-mediated membrane fusion
2025-12-18
-
[Nature Communications] Long-term protection from naturally acquired immunity against hepatitis E virus reinfection
2025-12-17
-
[Gut] Engineered virus-hunter vaccine overcomes HBV immune tolerance
2025-11-08
-
[eClinicalMedicine] Evaluation and optimization of mumps-containing vaccination strategies: a study based on an individual-based stochastic model
2025-11-07
-
[Nature Biomedical Engineering] Nanobody-based combination vaccine using licensed protein nanoparticles protects animals against respiratory and viral infections
2025-10-24
-
The Neural Regulation of Aging and Cellular Protein Homeostasis
2025-10-18
-
Retrospecting SJA's Triumphs and the Evolution of Biomedicine
2025-10-17